Evidence map›Paper›PMID 17785369›Full record

ArticleArchives of disease in childhood2007

Paediatric prescribing of asthma drugs in the UK: are we sticking to the guideline?

Simon Cohen, Jonny Taitz, Adam Jaffé

Abstract read
In one paragraph

Article in Archives of disease in childhood, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Enhancing ventilation in homes of children with asthma: cost-effectiveness study alongside randomised controlled trial.The British journal of general practice : the journal of the Royal College of General Practitioners · 2011
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Montelukast use-a 19-year nationwide drug utilisation study.European journal of clinical pharmacology · 2017
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Simon CohenSydney Children's Hospital and University of New South Wales, High Street, Randwick, NSW 2031, Australia. simoncohen11@yahoo.co.uk
Jonny Taitz
Adam Jaffé

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAsthma guidelines should lead to improved, more rational asthma medication prescribing. The aims of this study were to assess trends in paediatric asthma drug prescribing in the UK and to assess the potential impact of the publication of the British Thoracic Society (BTS) asthma guideline.

methodsThe estimated community paediatric prescribing figures for asthma medications in the UK were studied using data from the NHS Information Centre for Health and Social Care for the years 2000-2006.

resultsThe numbers of prescriptions for bronchodilator syrups decreased by 60% from 2000 to 2006. However, this still represents 121,000 prescriptions for bronchodilator syrups in 2006 despite minimal recommendations for their use. The percentage of steroid inhalers prescribed as combination inhalers of a steroid and a long-acting beta agonist increased from 2.6% in 2000 to 20.6% in 2006.

conclusionsSteroid-alone inhalers should be the mainstay for the vast majority of patients with asthma who require controller medications. The increase in the number of combination inhalers prescribed is not consistent with the guideline recommendations that combination inhalers should only be introduced in those patients with asthma not controlled on adequate doses of inhaled steroids. Further education of health professionals is required.

Indexed as

Administration, InhalationAdministration, OralAdolescentAsthmaBronchodilator AgentsChildChild, PreschoolDrug PrescriptionsFemaleGuideline AdherenceHumansMalePractice Guidelines as TopicUnited KingdomBronchodilator Agents

Identifiers

PMID17785369
PMCPMC2083219

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.